OMI Stock Overview
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Owens & Minor, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.74 |
| 52 Week High | US$28.35 |
| 52 Week Low | US$13.34 |
| Beta | 0.47 |
| 1 Month Change | -2.90% |
| 3 Month Change | 22.84% |
| 1 Year Change | 69.34% |
| 3 Year Change | -32.84% |
| 5 Year Change | 642.94% |
| Change since IPO | 363.88% |
Recent News & Updates
Owens & Minor (NYSE:OMI) Might Have The Makings Of A Multi-Bagger
Mar 29
Improved Revenues Required Before Owens & Minor, Inc. (NYSE:OMI) Stock's 25% Jump Looks Justified
Mar 02Recent updates
Owens & Minor (NYSE:OMI) Might Have The Makings Of A Multi-Bagger
Mar 29Improved Revenues Required Before Owens & Minor, Inc. (NYSE:OMI) Stock's 25% Jump Looks Justified
Mar 02Owens & Minor, Inc.'s (NYSE:OMI) Intrinsic Value Is Potentially 93% Above Its Share Price
Feb 12Owens & Minor (NYSE:OMI) Seems To Be Using A Lot Of Debt
Jan 17Owens & Minor, Inc.'s (NYSE:OMI) Low P/S No Reason For Excitement
Dec 25Owens & Minor: Aggressive Long-Term Targets May Not Be Reached
Dec 09These 4 Measures Indicate That Owens & Minor (NYSE:OMI) Is Using Debt Extensively
Oct 06Owens & Minor: Compressed Multiples Appear Justified, Reiterate Hold
Sep 28There Are Reasons To Feel Uneasy About Owens & Minor's (NYSE:OMI) Returns On Capital
Aug 10Potential Turnaround In Owens & Minor (Rating Upgrade)
Jul 18Owens & Minor (NYSE:OMI) Seems To Be Using A Lot Of Debt
Jul 06Owens & Minor (NYSE:OMI) Use Of Debt Could Be Considered Risky
Mar 30Owens & Minor, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 03Owens & Minor (NYSE:OMI) Might Be Having Difficulty Using Its Capital Effectively
Mar 01Is Owens & Minor (NYSE:OMI) Using Too Much Debt?
Dec 04Owens & Minor Q3 2022 Earnings Preview
Nov 01Owens & Minor: Not So Healthy
Oct 09Is Owens & Minor (NYSE:OMI) A Risky Investment?
Sep 04Owens & Minor: Balanced Debate, Split Between Profitability And Valuation
Aug 10Owens & Minor Q2 2022 Earnings Preview
Aug 02Is Owens & Minor (NYSE:OMI) Using Too Much Debt?
Jun 06Owens & Minor: When To Buy A No-Dividend, BB-Rated Company
May 04Is Now The Time To Put Owens & Minor (NYSE:OMI) On Your Watchlist?
Apr 08Owens & Minor, Inc. (NYSE:OMI) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 25Owens & Minor: Not A Minor Deal
Feb 21With EPS Growth And More, Owens & Minor (NYSE:OMI) Is Interesting
Jan 06Owens & Minor: Pandemic Winner Has More Upside In 2022
Jan 05Owens & Minor - Improved, But Extreme Care Is Still Warranted
Oct 05Shareholder Returns
| OMI | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 3.2% | 2.0% | 1.2% |
| 1Y | 69.3% | 3.4% | 24.9% |
Price Volatility
| OMI volatility | |
|---|---|
| OMI Average Weekly Movement | 5.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Volatility Over Time: OMI's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1882 | 22,200 | Ed Pesicka | www.owens-minor.com |
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Owens & Minor, Inc. Fundamentals Summary
| OMI fundamental statistics | |
|---|---|
| Market cap | US$1.96b |
| Earnings (TTM) | -US$41.30m |
| Revenue (TTM) | US$10.33b |
0.2x
P/S Ratio-45.9x
P/E RatioIs OMI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMI income statement (TTM) | |
|---|---|
| Revenue | US$10.33b |
| Cost of Revenue | US$8.12b |
| Gross Profit | US$2.22b |
| Other Expenses | US$2.26b |
| Earnings | -US$41.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 03, 2024
| Earnings per share (EPS) | -0.54 |
| Gross Margin | 21.46% |
| Net Profit Margin | -0.40% |
| Debt/Equity Ratio | 225.6% |
How did OMI perform over the long term?
See historical performance and comparison